Repare Therapeutics Inc - to Initiate Phase 3 Trial of Lunresertib and Camonsertib in 2H 2025
Repare Therapeutics Inc - 將於2025年下半年開始Lunresertib和Camonsertib的第三階段試驗
Repare Therapeutics Inc - to Initiate Phase 3 Trial of Lunresertib and Camonsertib in 2H 2025
Repare Therapeutics Inc - 將於2025年下半年開始Lunresertib和Camonsertib的第三階段試驗
譯文內容由第三人軟體翻譯。